John W. Smither
Chief Financial Officer at Arcutis Biotherapeutics; Chief Financial Officer at MBX Biosciences; Director at Genelux.
- Rank
- 12736th of 14,644
- Companies held
- 4
- Largest holding
- ARQT, 68.9% of total
- Latest SEC filing
- Sep 4, 2026
What the $6.0M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Arcutis Biotherapeutics ARQT Common Stock | Through Trust | 141,392 | $27.17 | $3.8M | 63.8% | Form 4, Feb 13, 2024 |
| MBX Biosciences MBX Common Stock | Directly | 28,000 | $53.41 | $1.5M | 24.8% | Form 4, Aug 3, 2026 |
| Arcutis Biotherapeutics ARQT Common Stock | Directly | 11,365 | $27.17 | $309K | 5.1% | Form 4, Feb 13, 2024 |
| Genelux GNLX Common Stock | Directly | 91,403 | $2.28 | $208K | 3.5% | Form 4, Jul 1, 2026 |
| NewAmsterdam Pharma Company NAMS Ordinary Shares | Directly | 8,760 | $19.51 | $171K | 2.8% | Form 4, Sep 4, 2026 |
Share counts are the amounts John W. Smither reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 12733 | Nicholas C. Gangestad Sr. VP and CFO, Rockwell Automation. Charlotte, NC | $6.0M |
| 12734 | Paul Seavey EVP & Chief Financial Officer, Equity LifeStyle Properties. Chicago, IL | $6.0M |
| 12735 | Nitin Sood Chief Commercial Officer, MRD, Adaptive Biotechnologies. Seattle, WA | $6.0M |
| 12736 | John W. Smither Chief Financial Officer, Arcutis Biotherapeutics | $6.0M |
| 12737 | Valerie L. Jabbar Senior Vice President, The Kroger. Cincinnati, OH | $6.0M |
| 12738 | Clifton E. Sifford VICE CHAIR, INTERIM PRES & CEO, Shoe Station Group. Fort Mill, SC | $6.0M |
| 12739 | Livingston Satterthwaite Director, IDEX. Fremont, CA | $6.0M |
Other Arcutis Biotherapeutics insiders
All ARQT insiders- Bhaskar Chaudhuri$24.9MDirector. #4261 overall
- Todd Watanabe$21.1MSee Remarks. #4986 overall
- David W. Osborne$7.3MChief Technical Officer. #11068 overall
- Christopher Peetz$5.2MDirector. #2841 overall
- David Topper$5.0MChief Financial Officer. #14477 overall
- Larry Todd Edwards$4.8MSee Remarks. #6612 overall
Questions
How much stock does John W. Smither own?
John W. Smither holds $6,025,194 in listed stock based on SEC filings and current prices, mostly Arcutis Biotherapeutics (ARQT). That ranks 12736th on the Stock Rich List.
Is this John W. Smither's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did John W. Smither last buy or sell stock?
The most recent open-market trade on file is a sale of 1,600 NAMS shares on Sep 4, 2026 at $25.32.